聚甲基酸诱导限制性通风缺陷,并改变小鼠的肺抵抗力和服从性
Yoon Hee Park1, Sang-Hoon Jeong1, Hong Lee1
1Medical Science Research Center, Korea University Ansan Hospital, Korea University College of Medicine, 123 Jeokgeum-ro, Danwon-gu, Ansan-si 15355, Gyeonggi-do, Republic of Korea.
Toxics
|November 26, 2024
概括
聚甲基胺酸盐 (PHMG-p) 暴露会导致肺损伤,导致小鼠的限制性肺功能缺陷和纤维化. 这些影响是剂量依赖的,与炎症和纤维化得分相关.
科学领域:
- 肺部毒理学 肺部毒理学
- 环境健康 环境健康
- 呼吸系统医学 呼吸系统医学
背景情况:
- 聚甲基酸 (PHMG-p) 是一种常见的加湿器消毒剂成分.
- 已知PHMG-p会引起肺炎,间歇性肺炎和纤维化.
- 在PHMG-p暴露后,肺功能测试 (PFT) 变化存在有限的研究.
研究的目的:
- 研究PHMG-p对小鼠肺部的急性和慢性影响.
- 为了确定PHMG-p诱导的肺损伤的剂量和时间反应关系.
- 为了将PFT变化与他的病理学发现相关联.
主要方法:
- 小鼠通过单次或多次插入暴露于PHMG-p.
- 进行肺功能测试 (PFTs) 来评估肺功能.
- 进行了组织病理学检查,以评估肺组织损伤.
- 分析了剂量和时间反应关系.
主要成果:
- 暴露于PHMG-p导致肺体积减少,抵抗力增加和服从性降低,这表明有限制性通风缺陷.
- 组织病理学发现增加了肺炎和纤维化.
- 肺功能和组织病理学变化是剂量依赖的.
- 肺部耐药性和服从性与炎症和纤维化得分有显著的相关性.
结论:
- 暴露于PHMG-p会导致小鼠的限制性通风缺陷.
- PHMG-p会导致剂量依赖的肺炎和纤维化.
- PFT变化与PHMG-p.p.引起的组织病理性肺损伤有关.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...